{"id":"https://openalex.org/W2005376214","doi":"https://doi.org/10.2147/ndt.s38377","title":"Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults","display_name":"Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults","publication_year":2013,"publication_date":"2013-02-01","ids":{"openalex":"https://openalex.org/W2005376214","doi":"https://doi.org/10.2147/ndt.s38377","mag":"2005376214","pmid":"https://pubmed.ncbi.nlm.nih.gov/23431065","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3575217"},"language":"en","primary_location":{"id":"doi:10.2147/ndt.s38377","doi":"https://doi.org/10.2147/ndt.s38377","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ndt.s38377","pdf_url":"https://www.dovepress.com/getfile.php?fileID=15182","source":{"id":"https://openalex.org/S124245730","display_name":"Neuropsychiatric Disease and Treatment","issn_l":"1176-6328","issn":["1176-6328","1178-2021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric Disease and Treatment","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=15182","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113517895","display_name":"James C. Ermer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"James Ermer","raw_affiliation_strings":["Shire Development LLC, Wayne, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Development LLC, Wayne, PA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richards","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richards","raw_affiliation_strings":["Shire Development LLC, Wayne, PA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Development LLC, Wayne, PA,","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061427649","display_name":"Kenneth C. Lasseter","orcid":"https://orcid.org/0000-0001-8175-2199","observed_orcids":["https://orcid.org/0000-0001-8175-2199"]},"institutions":[{"id":"https://openalex.org/I4210123890","display_name":"Clinical Pharmacology of Miami","ror":"https://ror.org/02wvtac27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210123890"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Lasseter","raw_affiliation_strings":["Clinical Pharmacology of Miami, Inc., Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology of Miami, Inc., Miami, FL, USA","institution_ids":["https://openalex.org/I4210123890"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108523812","display_name":"Adeyi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adeyi","raw_affiliation_strings":["Shire Development LLC, Wayne, PA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Development LLC, Wayne, PA,","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098064363","display_name":"Corcoran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corcoran","raw_affiliation_strings":["Shire Development LLC, Wayne, PA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Development LLC, Wayne, PA,","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030758862","display_name":"Patrick T. Martin","orcid":"https://orcid.org/0000-0002-2583-4648","observed_orcids":["https://orcid.org/0000-0002-2583-4648"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Martin","raw_affiliation_strings":["Shire Development LLC, Wayne, PA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Development LLC, Wayne, PA,","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038119693","display_name":"Bev Stanton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bev Stanton","raw_affiliation_strings":["Shire Development LLC, Wayne, PA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shire Development LLC, Wayne, PA,","institution_ids":["https://openalex.org/I4210140176"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113517895"],"corresponding_institution_ids":["https://openalex.org/I4210140176"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":3.0999,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.90485644,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"9","issue":null,"first_page":"219","last_page":"219"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.43799999356269836,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.43799999356269836,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.24719999730587006,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.1046999990940094,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lisdexamfetamine-dimesylate","display_name":"lisdexamfetamine dimesylate","score":0.9850000143051147},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9589999914169312},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.9509999752044678},{"id":"https://openalex.org/keywords/d-amphetamine","display_name":"d-amphetamine","score":0.7039999961853027},{"id":"https://openalex.org/keywords/stimulants","display_name":"stimulants","score":0.7609999775886536},{"id":"https://openalex.org/keywords/creatinine-clearance","display_name":"creatinine clearance","score":0.8629999756813049},{"id":"https://openalex.org/keywords/age-differences","display_name":"age differences","score":0.6330000162124634},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.7870000004768372},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.5839999914169312},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9431576728820801},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.7551490068435669},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7346779704093933},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6816303133964539},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.5359379053115845},{"id":"https://openalex.org/C2781291010","wikidata":"https://www.wikidata.org/wiki/Q178580","display_name":"Period (music)","level":2,"score":0.43617311120033264},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35887402296066284},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.12663930654525757},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07413819432258606},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.2147/ndt.s38377","doi":"https://doi.org/10.2147/ndt.s38377","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ndt.s38377","pdf_url":"https://www.dovepress.com/getfile.php?fileID=15182","source":{"id":"https://openalex.org/S124245730","display_name":"Neuropsychiatric Disease and Treatment","issn_l":"1176-6328","issn":["1176-6328","1178-2021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric Disease and Treatment","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2576319","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3575217","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3575217","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3575217","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatr Dis Treat","raw_type":"Text"},{"id":"pmid:23431065","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23431065","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric disease and treatment","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.789.8505","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.789.8505","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/28/b0/ndt-9-219.PMC3575217.pdf","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:93ce6901f49c418ab957181da11bf564","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/93ce6901f49c418ab957181da11bf564","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 219-229 (2013)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/12192","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/double-blind-placebo-controlled-two-period-crossover-trial-to-examine--peer-reviewed-article-NDT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/ndt.s38377","doi":"https://doi.org/10.2147/ndt.s38377","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ndt.s38377","pdf_url":"https://www.dovepress.com/getfile.php?fileID=15182","source":{"id":"https://openalex.org/S124245730","display_name":"Neuropsychiatric Disease and Treatment","issn_l":"1176-6328","issn":["1176-6328","1178-2021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric Disease and Treatment","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005376214.pdf","grobid_xml":"https://content.openalex.org/works/W2005376214.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1481796766","https://openalex.org/W1821665499","https://openalex.org/W1974896478","https://openalex.org/W1979206088","https://openalex.org/W1980572298","https://openalex.org/W1992488678","https://openalex.org/W1997542915","https://openalex.org/W2007414208","https://openalex.org/W2012154384","https://openalex.org/W2012950683","https://openalex.org/W2023262882","https://openalex.org/W2029958335","https://openalex.org/W2038799661","https://openalex.org/W2055401851","https://openalex.org/W2082580890","https://openalex.org/W2087053197","https://openalex.org/W2125661463","https://openalex.org/W2127512142","https://openalex.org/W2129620184","https://openalex.org/W2482934514","https://openalex.org/W2614781785"],"related_works":["https://openalex.org/W2029958335","https://openalex.org/W2750699103","https://openalex.org/W2990244523","https://openalex.org/W4240482213","https://openalex.org/W2012950683","https://openalex.org/W3097323064","https://openalex.org/W2620176345","https://openalex.org/W1070976522","https://openalex.org/W2523158836","https://openalex.org/W3087429211"],"abstract_inverted_index":{"BACKGROUND:":[0],"Pharmacokinetic":[1],"and":[2,48,52,69,73,89,100,114,133,159,174,191,204,210,221,247,251,279,298,318,337,349,358],"safety":[3,74,380],"data":[4],"on":[5],"stimulants":[6],"in":[7,29,84,124,177,261,366,389],"older":[8,30],"adults":[9,39],"are":[10],"limited.":[11],"The":[12,379],"objective":[13],"of":[14,22,59,353,382],"this":[15,34],"study":[16,392],"was":[17,93,126,152,171,184,197,218,227,359,384],"to":[18,149,166,213,229,272,293,296,300,311,315,320,329,334,339,361,377],"characterize":[19],"the":[20,109,118,141,283],"pharmacokinetics":[21],"lisdexamfetamine":[23],"dimesylate":[24],"(LDX),":[25],"a":[26],"d-amphetamine":[27,68,122,182,354],"prodrug,":[28],"adults.":[31],"METHODS:":[32],"In":[33,108,274],"two-period":[35],"crossover":[36],"trial,":[37],"healthy":[38],"(n":[40],"=":[41],"47)":[42],"stratified":[43],"by":[44],"age":[45,357],"(55-64,":[46],"65-74,":[47,88,113,278],"\u2265":[49,90,115,248,280],"75":[50,91,116,249,281],"years)":[51],"gender":[53],"received":[54],"randomized,":[55],"double-blind,":[56],"single":[57],"doses":[58],"LDX":[60,71,270,373,383],"50":[61],"mg":[62],"or":[63,264,368],"placebo.":[64],"Baseline":[65],"creatinine":[66,82,231,362],"clearance,":[67],"intact":[70],"pharmacokinetics,":[72],"were":[75,267,345,374],"assessed.":[76],"RESULTS:":[77],"Mean":[78],"(\u00b1standard":[79],"deviation)":[80],"baseline":[81,230,288],"clearance":[83,226],"participants":[85,234,275],"aged":[86,111,235,245,276],"55-64,":[87,112,277],"years":[92,237],"102.5":[94],"\u00b1":[95,98,102,128,131,135,154,157,161,186,189,193,199,202,206],"26.1,":[96],"105.3":[97],"23.1,":[99],"94.9":[101],"27.3":[103],"mL":[104],"per":[105,303],"minute,":[106],"respectively.":[107,224],"groups":[110],"years,":[117,282],"mean":[119,179,284],"maximum":[120,180],"plasma":[121,169,181,216],"concentration":[123,142,170,183,217],"men":[125,348],"44.2":[127],"11.1,":[129],"47.7":[130],"7.0,":[132],"53.4":[134],"19.4":[136],"ng/mL,":[137,195],"respectively;":[138],"area":[139],"under":[140],"time":[143,146,165,212],"curve":[144],"from":[145,286,291,309,327,332],"0":[147],"extrapolated":[148],"infinity":[150],"(AUC(0-inf))":[151],"915.0":[153],"164.9,":[155],"1123.0":[156],"227.0,":[158],"1325.0":[160],"464.4":[162],"nghour/mL;":[163],"median":[164,211],"reach":[167,214],"peak":[168,215],"4.5,":[172],"3.5,":[173,219],"5.5":[175,222],"hours;":[176],"women,":[178],"51.0":[185],"6.7,":[187],"50.2":[188],"6.8,":[190],"64.3":[192],"12.1":[194],"AUC(0-inf)":[196],"1034.5":[198],"154.6,":[200],"988.4":[201],"80.5,":[203],"1347.8":[205],"198.9":[207],"ng":[208],"hour/mL,":[209],"4.1,":[220],"hours,":[223],"d-Amphetamine":[225],"unrelated":[228,360],"clearance.":[232,363],"Five":[233],"55-64":[236],"reported":[238],"treatment-emergent":[239],"adverse":[240],"events":[241],"(versus":[242,256],"one":[243,257],"each":[244],"65-74":[246],"years),":[250],"as":[252],"did":[253],"six":[254],"women":[255],"man).":[258],"No":[259,364],"trends":[260,365],"blood":[262,307,325,369],"pressure":[263,326,370],"pulse":[265,289,367],"changes":[266,344,371],"seen":[268,375],"with":[269,356,372,386],"according":[271,376],"age.":[273,378],"change":[285],"time-matched":[287],"ranged":[290],"-5.0":[292],"14.7,":[294],"-4.3":[295],"9.5,":[297],"-3.0":[299],"14.7":[301],"beats":[302],"minute;":[304],"for":[305,323],"systolic":[306],"pressure,":[308],"-3.9":[310],"18.5":[312],"mmHg,":[313,317,331,336],"-2.1":[314],"14.5":[316],"-5.9":[319],"16.0":[321],"mmHg;":[322],"diastolic":[324],"-2.5":[328],"8.3":[330],"-0.8":[333],"9.4":[335],"-0.6":[338],"9.5":[340],"mmHg.":[341],"Vital":[342],"sign":[343],"similar":[346],"between":[347],"women.":[350],"CONCLUSION:":[351],"Clearance":[352],"decreased":[355],"profile":[381],"consistent":[385],"prior":[387],"observations":[388],"younger":[390],"adult":[391],"participants.":[393]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}